Clinical trials
Completed Lymphoma, Large B-Cell, Diffuse trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swiss Cancer Institute | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 3 |
| Lymphoma Study Association | 3 |
| Celgene | 2 |
| Children's Oncology Group | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Novartis Pharmaceuticals | 2 |
| Debiopharm International SA | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 29 |
| Lymphoma | 16 |
| Lymphoma, Follicular | 10 |
| Lymphoma, Mantle-Cell | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Burkitt Lymphoma | 8 |
| Lymphoma, Large-Cell, Immunoblastic | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Lymphoma, B-Cell, Marginal Zone | 6 |
| Immunoblastic Lymphadenopathy | 5 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.